s body weight (1mg of WT1 peptide for body weight (BW) &lt

2 trials

Sponsors

Shinshu University, Nagano Children's Hospital

Conditions

Pediatric cancersPediatric refractory solid tumors or leukemia

Phase 1

Phase I clinical trial of WT1 peptide vaccine therapy for pediatric cancers

Active, not recruitingJPRN-UMIN000011030

Shinshu UniversityPediatric cancers

Start: 2013-07-01Target: 15Updated: 2026-06-29

Unknown Phase

Phase 1 clinical trial of WT1 peptide vaccine therapy for pediatric cancers.

Active, not recruitingJPRN-UMIN000027867

Nagano Children's HospitalPediatric refractory solid tumors or leukemia

Start: 2017-06-27Target: 15Updated: 2026-06-29